Noncommunicable diseases (NCDs) are responsible for 71% of all worldwide mortality each year. Despite a wealth of knowledge that offers evidence-based expert guidance for managing illness and preventing risk, in many parts of the world whether in high-income or low-income countries, we are still...
IAPO is proud to be part of the #TeamVaccines, a global digital campaign designed to build confidence in COVID-19 vaccines launched by the International Federation of Pharmaceutical Manufacturers & associations (IFPMA). We support this campaign because we believe vaccination is not just an...
Endorse and sign the call Patients, Civil Society and Youth Organisations, Products Development Partnerships, Health and Pharmaceutical Industries, and all stakeholders who are striving to improve global public health - welcome the African Medicines Agency (AMA) Treaty made at the 32nd ordinary...
2020 was a turning point for us at IAPO, where the COVID-19 pandemic and all its lessons gave us an opportunity to review, adapt and improve our work, and more importantly strengthen the IAPO membership community. We worked hard last year to amplify the patients’ voice at various fronts -...
The 148th session of the World Health Organization’s Executive Board (EB) took place on 18-26 January 2021 in Geneva, Switzerland with a focus on the challenges of COVID-19, the need to strengthen health systems. The Governing Board Chair, and Governing Board Secretary were able to attend a...
We at IAPO are extremely delighted that on Thursday 21st January 2020, the World Health Organization (WHO) Member States and non-state actors expressed their unanimous support to the proposed Global Patient Safety Action Plan 2021-2030 as a key instrument to guide patient safety improvements at all...
The International Alliance of Patients’ Organisations (IAPO) collaborated with BD–Europe to amplify the voices of patients who have been afflicted with healthcare-associated infections (HAIs), sepsis, antimicrobial resistance (AMR) or medication errors. As part of this Voices of Safety...
In 2020, IAPO launched the COVID-19 Response Activity Grant Scheme to support IAPO members working on the frontline to support patients during the pandemic. Through a competitive 2-stage selection process initiated via the 9 th Global Patients Congress (GPC 2020) Open Call, we invited our Member...
The 2nd Asia Pacific Patients Congress was held as IAPO’s second fully digital congress on 3-4 December 2020 with over 3000 registered from 66 countries with 298 patient groups, who attended 20 sessions with 66 speakers from 16 countries. Patient groups and thousands of attendees drew...
Antimicrobial resistance (AMR) is a natural process of pathogens’ adaptation to the drugs we use to kill them, which should normally have a slow evolution-like pace. Our inappropriate use of common antibiotics, antiviral agents and other drugs on all fronts of human and animal health...

Pages